nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN3B—testis—ovarian cancer	0.0098	0.124	CbGeAlD
Acamprosate—GRM5—female reproductive system—ovarian cancer	0.00765	0.0969	CbGeAlD
Acamprosate—GRM5—testis—ovarian cancer	0.00618	0.0782	CbGeAlD
Acamprosate—GRIN2C—testis—ovarian cancer	0.00471	0.0596	CbGeAlD
Acamprosate—SLC36A1—gonad—ovarian cancer	0.00448	0.0568	CbGeAlD
Acamprosate—SLC36A1—uterus—ovarian cancer	0.00445	0.0564	CbGeAlD
Acamprosate—GRIN2D—testis—ovarian cancer	0.00438	0.0554	CbGeAlD
Acamprosate—GRIN3A—testis—ovarian cancer	0.00411	0.0521	CbGeAlD
Acamprosate—SLC36A1—female reproductive system—ovarian cancer	0.004	0.0507	CbGeAlD
Acamprosate—SLC36A1—bone marrow—ovarian cancer	0.00378	0.0479	CbGeAlD
Acamprosate—GRIN2A—vagina—ovarian cancer	0.00364	0.0461	CbGeAlD
Acamprosate—SLC36A1—female gonad—ovarian cancer	0.00364	0.0461	CbGeAlD
Acamprosate—SLC36A1—vagina—ovarian cancer	0.00362	0.0458	CbGeAlD
Acamprosate—GRIN2A—testis—ovarian cancer	0.00325	0.0412	CbGeAlD
Acamprosate—SLC36A1—testis—ovarian cancer	0.00323	0.0409	CbGeAlD
Acamprosate—SLC36A1—lymph node—ovarian cancer	0.00234	0.0297	CbGeAlD
Acamprosate—GABRB3—gonad—ovarian cancer	0.00218	0.0276	CbGeAlD
Acamprosate—GABRB3—female reproductive system—ovarian cancer	0.00195	0.0247	CbGeAlD
Acamprosate—GABRB3—testis—ovarian cancer	0.00157	0.0199	CbGeAlD
Acamprosate—Hypotension—Paclitaxel—ovarian cancer	0.000579	0.000793	CcSEcCtD
Acamprosate—Headache—Vinorelbine—ovarian cancer	0.000578	0.000791	CcSEcCtD
Acamprosate—Syncope—Docetaxel—ovarian cancer	0.000578	0.00079	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—ovarian cancer	0.000577	0.00079	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—ovarian cancer	0.000577	0.00079	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—ovarian cancer	0.000577	0.00079	CcSEcCtD
Acamprosate—Leukopenia—Docetaxel—ovarian cancer	0.000576	0.000789	CcSEcCtD
Acamprosate—Pollakiuria—Epirubicin—ovarian cancer	0.000576	0.000788	CcSEcCtD
Acamprosate—Eosinophilia—Doxorubicin—ovarian cancer	0.000571	0.000782	CcSEcCtD
Acamprosate—Palpitations—Docetaxel—ovarian cancer	0.000569	0.000779	CcSEcCtD
Acamprosate—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000569	0.000779	CcSEcCtD
Acamprosate—Weight increased—Epirubicin—ovarian cancer	0.000567	0.000777	CcSEcCtD
Acamprosate—Loss of consciousness—Docetaxel—ovarian cancer	0.000566	0.000775	CcSEcCtD
Acamprosate—Pancreatitis—Doxorubicin—ovarian cancer	0.000566	0.000774	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000565	0.000773	CcSEcCtD
Acamprosate—Weight decreased—Epirubicin—ovarian cancer	0.000564	0.000772	CcSEcCtD
Acamprosate—Hyperglycaemia—Epirubicin—ovarian cancer	0.000562	0.00077	CcSEcCtD
Acamprosate—Cough—Docetaxel—ovarian cancer	0.000562	0.000769	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—ovarian cancer	0.000562	0.000769	CcSEcCtD
Acamprosate—Insomnia—Paclitaxel—ovarian cancer	0.000561	0.000768	CcSEcCtD
Acamprosate—Pneumonia—Epirubicin—ovarian cancer	0.000559	0.000765	CcSEcCtD
Acamprosate—Convulsion—Docetaxel—ovarian cancer	0.000558	0.000764	CcSEcCtD
Acamprosate—Paraesthesia—Paclitaxel—ovarian cancer	0.000557	0.000762	CcSEcCtD
Acamprosate—Hypertension—Docetaxel—ovarian cancer	0.000556	0.000761	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—ovarian cancer	0.000555	0.000759	CcSEcCtD
Acamprosate—Dyspnoea—Paclitaxel—ovarian cancer	0.000553	0.000757	CcSEcCtD
Acamprosate—Somnolence—Paclitaxel—ovarian cancer	0.000551	0.000755	CcSEcCtD
Acamprosate—Chest pain—Docetaxel—ovarian cancer	0.000548	0.00075	CcSEcCtD
Acamprosate—Arthralgia—Docetaxel—ovarian cancer	0.000548	0.00075	CcSEcCtD
Acamprosate—Myalgia—Docetaxel—ovarian cancer	0.000548	0.00075	CcSEcCtD
Acamprosate—Nausea—Vinorelbine—ovarian cancer	0.000548	0.00075	CcSEcCtD
Acamprosate—Dyspepsia—Paclitaxel—ovarian cancer	0.000546	0.000747	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000545	0.000745	CcSEcCtD
Acamprosate—Stomatitis—Epirubicin—ovarian cancer	0.000542	0.000742	CcSEcCtD
Acamprosate—Urinary tract infection—Epirubicin—ovarian cancer	0.00054	0.00074	CcSEcCtD
Acamprosate—Decreased appetite—Paclitaxel—ovarian cancer	0.000539	0.000738	CcSEcCtD
Acamprosate—Dry mouth—Docetaxel—ovarian cancer	0.000536	0.000734	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000535	0.000733	CcSEcCtD
Acamprosate—Sweating—Epirubicin—ovarian cancer	0.000533	0.000729	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—ovarian cancer	0.000533	0.000729	CcSEcCtD
Acamprosate—Constipation—Paclitaxel—ovarian cancer	0.00053	0.000726	CcSEcCtD
Acamprosate—Pain—Paclitaxel—ovarian cancer	0.00053	0.000726	CcSEcCtD
Acamprosate—Haematuria—Epirubicin—ovarian cancer	0.00053	0.000725	CcSEcCtD
Acamprosate—Confusional state—Docetaxel—ovarian cancer	0.00053	0.000725	CcSEcCtD
Acamprosate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000527	0.000721	CcSEcCtD
Acamprosate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000526	0.000719	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—ovarian cancer	0.000525	0.000719	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—ovarian cancer	0.000524	0.000718	CcSEcCtD
Acamprosate—Infection—Docetaxel—ovarian cancer	0.000522	0.000715	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—ovarian cancer	0.000522	0.000714	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00052	0.000712	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—ovarian cancer	0.000517	0.000708	CcSEcCtD
Acamprosate—Shock—Docetaxel—ovarian cancer	0.000517	0.000708	CcSEcCtD
Acamprosate—Thrombocytopenia—Docetaxel—ovarian cancer	0.000515	0.000704	CcSEcCtD
Acamprosate—Tachycardia—Docetaxel—ovarian cancer	0.000513	0.000702	CcSEcCtD
Acamprosate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000511	0.000699	CcSEcCtD
Acamprosate—Skin disorder—Docetaxel—ovarian cancer	0.000511	0.000699	CcSEcCtD
Acamprosate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000507	0.000694	CcSEcCtD
Acamprosate—Haemoglobin—Epirubicin—ovarian cancer	0.000502	0.000686	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—ovarian cancer	0.000501	0.000686	CcSEcCtD
Acamprosate—Anorexia—Docetaxel—ovarian cancer	0.000501	0.000686	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—ovarian cancer	0.0005	0.000685	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—ovarian cancer	0.0005	0.000684	CcSEcCtD
Acamprosate—Hepatitis—Epirubicin—ovarian cancer	0.000499	0.000683	CcSEcCtD
Acamprosate—Haemorrhage—Epirubicin—ovarian cancer	0.000499	0.000683	CcSEcCtD
Acamprosate—Hypoaesthesia—Epirubicin—ovarian cancer	0.000497	0.00068	CcSEcCtD
Acamprosate—Pharyngitis—Epirubicin—ovarian cancer	0.000495	0.000678	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—ovarian cancer	0.000493	0.000675	CcSEcCtD
Acamprosate—Urticaria—Paclitaxel—ovarian cancer	0.000493	0.000674	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—ovarian cancer	0.000492	0.000673	CcSEcCtD
Acamprosate—Hypotension—Docetaxel—ovarian cancer	0.000491	0.000672	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—ovarian cancer	0.00049	0.000671	CcSEcCtD
Acamprosate—Body temperature increased—Paclitaxel—ovarian cancer	0.00049	0.000671	CcSEcCtD
Acamprosate—Abdominal pain—Paclitaxel—ovarian cancer	0.00049	0.000671	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—ovarian cancer	0.000485	0.000664	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—ovarian cancer	0.000481	0.000658	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000479	0.000655	CcSEcCtD
Acamprosate—Insomnia—Docetaxel—ovarian cancer	0.000475	0.000651	CcSEcCtD
Acamprosate—Paraesthesia—Docetaxel—ovarian cancer	0.000472	0.000646	CcSEcCtD
Acamprosate—Dyspnoea—Docetaxel—ovarian cancer	0.000469	0.000641	CcSEcCtD
Acamprosate—Somnolence—Docetaxel—ovarian cancer	0.000467	0.00064	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—ovarian cancer	0.000465	0.000637	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—ovarian cancer	0.000464	0.000635	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—ovarian cancer	0.000463	0.000634	CcSEcCtD
Acamprosate—Dyspepsia—Docetaxel—ovarian cancer	0.000463	0.000633	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—ovarian cancer	0.000462	0.000632	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—ovarian cancer	0.000462	0.000632	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000459	0.000629	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—ovarian cancer	0.000458	0.000627	CcSEcCtD
Acamprosate—Decreased appetite—Docetaxel—ovarian cancer	0.000457	0.000625	CcSEcCtD
Acamprosate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000457	0.000625	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—ovarian cancer	0.000455	0.000623	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000454	0.000621	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—ovarian cancer	0.000451	0.000617	CcSEcCtD
Acamprosate—Pain—Docetaxel—ovarian cancer	0.000449	0.000615	CcSEcCtD
Acamprosate—Constipation—Docetaxel—ovarian cancer	0.000449	0.000615	CcSEcCtD
Acamprosate—Chills—Epirubicin—ovarian cancer	0.000448	0.000613	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—ovarian cancer	0.000445	0.000609	CcSEcCtD
Acamprosate—Asthenia—Paclitaxel—ovarian cancer	0.000445	0.000609	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—ovarian cancer	0.000441	0.000604	CcSEcCtD
Acamprosate—Pruritus—Paclitaxel—ovarian cancer	0.000439	0.0006	CcSEcCtD
Acamprosate—Mental disorder—Epirubicin—ovarian cancer	0.000437	0.000598	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—ovarian cancer	0.000434	0.000595	CcSEcCtD
Acamprosate—Feeling abnormal—Docetaxel—ovarian cancer	0.000433	0.000593	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—ovarian cancer	0.00043	0.000589	CcSEcCtD
Acamprosate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00043	0.000588	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—ovarian cancer	0.000428	0.000586	CcSEcCtD
Acamprosate—Tension—Epirubicin—ovarian cancer	0.000426	0.000583	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—ovarian cancer	0.000425	0.000582	CcSEcCtD
Acamprosate—Diarrhoea—Paclitaxel—ovarian cancer	0.000424	0.000581	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—ovarian cancer	0.000422	0.000577	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—MAPK3—ovarian cancer	0.000421	0.00221	CbGpPWpGaD
Acamprosate—Back pain—Epirubicin—ovarian cancer	0.00042	0.000575	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.00042	0.00221	CbGpPWpGaD
Acamprosate—Muscle spasms—Epirubicin—ovarian cancer	0.000418	0.000572	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—ovarian cancer	0.000417	0.000571	CcSEcCtD
Acamprosate—Body temperature increased—Docetaxel—ovarian cancer	0.000416	0.000569	CcSEcCtD
Acamprosate—Abdominal pain—Docetaxel—ovarian cancer	0.000416	0.000569	CcSEcCtD
Acamprosate—Chills—Doxorubicin—ovarian cancer	0.000414	0.000567	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—MAPK1—ovarian cancer	0.000411	0.00216	CbGpPWpGaD
Acamprosate—Dizziness—Paclitaxel—ovarian cancer	0.00041	0.000561	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.000409	0.00215	CbGpPWpGaD
Acamprosate—Alopecia—Doxorubicin—ovarian cancer	0.000408	0.000558	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—ovarian cancer	0.000408	0.00214	CbGpPWpGaD
Acamprosate—Mental disorder—Doxorubicin—ovarian cancer	0.000405	0.000554	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—ovarian cancer	0.000403	0.000552	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—ovarian cancer	0.000402	0.00055	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—ovarian cancer	0.000401	0.00055	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—MAPK1—ovarian cancer	0.0004	0.0021	CbGpPWpGaD
Acamprosate—Agitation—Epirubicin—ovarian cancer	0.000399	0.000546	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CDKN1B—ovarian cancer	0.000398	0.00209	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—ovarian cancer	0.000397	0.00209	CbGpPWpGaD
Acamprosate—Flatulence—Doxorubicin—ovarian cancer	0.000396	0.000542	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—ovarian cancer	0.000395	0.00208	CbGpPWpGaD
Acamprosate—Tension—Doxorubicin—ovarian cancer	0.000394	0.00054	CcSEcCtD
Acamprosate—Vomiting—Paclitaxel—ovarian cancer	0.000394	0.00054	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—ovarian cancer	0.000394	0.000539	CcSEcCtD
Acamprosate—Malaise—Epirubicin—ovarian cancer	0.000392	0.000536	CcSEcCtD
Acamprosate—Rash—Paclitaxel—ovarian cancer	0.000391	0.000535	CcSEcCtD
Acamprosate—Dermatitis—Paclitaxel—ovarian cancer	0.000391	0.000535	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—ovarian cancer	0.00039	0.000534	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—ovarian cancer	0.00039	0.000534	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00039	0.00205	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—ovarian cancer	0.00039	0.00205	CbGpPWpGaD
Acamprosate—Syncope—Epirubicin—ovarian cancer	0.00039	0.000533	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—ovarian cancer	0.000389	0.00205	CbGpPWpGaD
Acamprosate—Leukopenia—Epirubicin—ovarian cancer	0.000389	0.000532	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—ovarian cancer	0.000389	0.000532	CcSEcCtD
Acamprosate—Headache—Paclitaxel—ovarian cancer	0.000388	0.000532	CcSEcCtD
Acamprosate—Hypersensitivity—Docetaxel—ovarian cancer	0.000387	0.00053	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—ovarian cancer	0.000387	0.00203	CbGpPWpGaD
Acamprosate—Muscle spasms—Doxorubicin—ovarian cancer	0.000386	0.000529	CcSEcCtD
Acamprosate—Palpitations—Epirubicin—ovarian cancer	0.000384	0.000525	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—ovarian cancer	0.000382	0.000523	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CCND1—ovarian cancer	0.00038	0.00199	CbGpPWpGaD
Acamprosate—Cough—Epirubicin—ovarian cancer	0.000379	0.000519	CcSEcCtD
Acamprosate—Asthenia—Docetaxel—ovarian cancer	0.000377	0.000516	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—ovarian cancer	0.000376	0.000515	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.000376	0.00197	CbGpPWpGaD
Acamprosate—Hypertension—Epirubicin—ovarian cancer	0.000375	0.000513	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000373	0.00051	CcSEcCtD
Acamprosate—Pruritus—Docetaxel—ovarian cancer	0.000372	0.000509	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—ovarian cancer	0.000371	0.000508	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—ovarian cancer	0.00037	0.000506	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—ovarian cancer	0.00037	0.000506	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—ovarian cancer	0.00037	0.000506	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—ovarian cancer	0.000369	0.000506	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000369	0.00194	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—ovarian cancer	0.000369	0.00194	CbGpPWpGaD
Acamprosate—Anxiety—Epirubicin—ovarian cancer	0.000369	0.000504	CcSEcCtD
Acamprosate—Nausea—Paclitaxel—ovarian cancer	0.000368	0.000504	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000367	0.000503	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—ovarian cancer	0.000365	0.0005	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000363	0.00191	CbGpPWpGaD
Acamprosate—Malaise—Doxorubicin—ovarian cancer	0.000362	0.000496	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—ovarian cancer	0.000362	0.000495	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MTOR—ovarian cancer	0.000362	0.0019	CbGpPWpGaD
Acamprosate—Vertigo—Doxorubicin—ovarian cancer	0.000361	0.000494	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—ovarian cancer	0.00036	0.000493	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—ovarian cancer	0.00036	0.000492	CcSEcCtD
Acamprosate—Diarrhoea—Docetaxel—ovarian cancer	0.00036	0.000492	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—ovarian cancer	0.000357	0.000489	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—ovarian cancer	0.000355	0.000486	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000355	0.00186	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000355	0.000485	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—ovarian cancer	0.000353	0.000484	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—MTOR—ovarian cancer	0.000353	0.00185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HDAC6—ovarian cancer	0.000352	0.00185	CbGpPWpGaD
Acamprosate—Infection—Epirubicin—ovarian cancer	0.000352	0.000482	CcSEcCtD
Acamprosate—Cough—Doxorubicin—ovarian cancer	0.000351	0.00048	CcSEcCtD
Acamprosate—Shock—Epirubicin—ovarian cancer	0.000349	0.000477	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000348	0.00183	CbGpPWpGaD
Acamprosate—Convulsion—Doxorubicin—ovarian cancer	0.000348	0.000477	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000348	0.00183	CbGpPWpGaD
Acamprosate—Dizziness—Docetaxel—ovarian cancer	0.000348	0.000476	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000347	0.00183	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Epirubicin—ovarian cancer	0.000347	0.000475	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—ovarian cancer	0.000347	0.000475	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—ovarian cancer	0.000346	0.000474	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TP53—ovarian cancer	0.000345	0.00181	CbGpPWpGaD
Acamprosate—Skin disorder—Epirubicin—ovarian cancer	0.000344	0.000471	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000343	0.000469	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—ovarian cancer	0.000342	0.000468	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—ovarian cancer	0.000342	0.000468	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—ovarian cancer	0.000342	0.000468	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—ovarian cancer	0.000341	0.000467	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00034	0.00179	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00034	0.000465	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—ovarian cancer	0.000338	0.000463	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—ovarian cancer	0.000338	0.000463	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—ovarian cancer	0.000336	0.00177	CbGpPWpGaD
Acamprosate—Dry mouth—Doxorubicin—ovarian cancer	0.000335	0.000458	CcSEcCtD
Acamprosate—Vomiting—Docetaxel—ovarian cancer	0.000334	0.000457	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000334	0.00175	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—ovarian cancer	0.000334	0.00175	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—ovarian cancer	0.000333	0.00175	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000333	0.00175	CbGpPWpGaD
Acamprosate—Rash—Docetaxel—ovarian cancer	0.000331	0.000454	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—ovarian cancer	0.000331	0.000453	CcSEcCtD
Acamprosate—Dermatitis—Docetaxel—ovarian cancer	0.000331	0.000453	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—ovarian cancer	0.000331	0.000453	CcSEcCtD
Acamprosate—Headache—Docetaxel—ovarian cancer	0.000329	0.000451	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000328	0.000449	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000326	0.00171	CbGpPWpGaD
Acamprosate—Infection—Doxorubicin—ovarian cancer	0.000326	0.000446	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—ovarian cancer	0.000324	0.0017	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000323	0.000442	CcSEcCtD
Acamprosate—Shock—Doxorubicin—ovarian cancer	0.000323	0.000442	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000321	0.00044	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—ovarian cancer	0.000321	0.000439	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000321	0.00168	CbGpPWpGaD
Acamprosate—Tachycardia—Doxorubicin—ovarian cancer	0.00032	0.000438	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—ovarian cancer	0.000319	0.000436	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—ovarian cancer	0.000318	0.000436	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000317	0.000434	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—ovarian cancer	0.000316	0.000433	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—ovarian cancer	0.000315	0.000431	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000313	0.00165	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK3—ovarian cancer	0.000313	0.00164	CbGpPWpGaD
Acamprosate—Anorexia—Doxorubicin—ovarian cancer	0.000313	0.000428	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000313	0.00164	CbGpPWpGaD
Acamprosate—Nausea—Docetaxel—ovarian cancer	0.000312	0.000427	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—ovarian cancer	0.000312	0.000427	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000312	0.00164	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—YAP1—ovarian cancer	0.000312	0.00164	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—APC—ovarian cancer	0.000311	0.00164	CbGpPWpGaD
Acamprosate—Decreased appetite—Epirubicin—ovarian cancer	0.000308	0.000422	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—ovarian cancer	0.000307	0.00042	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000306	0.000419	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—XIAP—ovarian cancer	0.000306	0.0016	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000305	0.0016	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—ovarian cancer	0.000305	0.0016	CbGpPWpGaD
Acamprosate—Pain—Epirubicin—ovarian cancer	0.000303	0.000415	CcSEcCtD
Acamprosate—Constipation—Epirubicin—ovarian cancer	0.000303	0.000415	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000301	0.00158	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000299	0.000409	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK1—ovarian cancer	0.000298	0.00156	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000298	0.00156	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—ovarian cancer	0.000298	0.00156	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SMARCA4—ovarian cancer	0.000298	0.00156	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—ovarian cancer	0.000297	0.000406	CcSEcCtD
Acamprosate—Paraesthesia—Doxorubicin—ovarian cancer	0.000295	0.000403	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000293	0.00154	CbGpPWpGaD
Acamprosate—Dyspnoea—Doxorubicin—ovarian cancer	0.000292	0.0004	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—ovarian cancer	0.000292	0.0004	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000292	0.00153	CbGpPWpGaD
Acamprosate—Somnolence—Doxorubicin—ovarian cancer	0.000292	0.000399	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000291	0.00153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EREG—ovarian cancer	0.000291	0.00153	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00029	0.000397	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—ovarian cancer	0.000289	0.000395	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—ovarian cancer	0.000287	0.00151	CbGpPWpGaD
Acamprosate—Decreased appetite—Doxorubicin—ovarian cancer	0.000285	0.00039	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000283	0.000388	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—ovarian cancer	0.000282	0.000385	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—ovarian cancer	0.000281	0.000384	CcSEcCtD
Acamprosate—Pain—Doxorubicin—ovarian cancer	0.000281	0.000384	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—ovarian cancer	0.00028	0.000384	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—ovarian cancer	0.00028	0.000384	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—ovarian cancer	0.00028	0.00147	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—ovarian cancer	0.000279	0.00147	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000273	0.00143	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—ovarian cancer	0.000272	0.00143	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PGR—ovarian cancer	0.000272	0.00143	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—ovarian cancer	0.00027	0.00037	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000269	0.00141	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000268	0.000367	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK3—ovarian cancer	0.000267	0.0014	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000265	0.00139	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000264	0.00139	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MET—ovarian cancer	0.000262	0.00138	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—ovarian cancer	0.000261	0.000358	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—ovarian cancer	0.000261	0.000357	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK3—ovarian cancer	0.00026	0.00137	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00026	0.00136	CbGpPWpGaD
Acamprosate—Abdominal pain—Doxorubicin—ovarian cancer	0.000259	0.000355	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—ovarian cancer	0.000259	0.000355	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—IL6ST—ovarian cancer	0.000257	0.00135	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000256	0.00135	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MET—ovarian cancer	0.000255	0.00134	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—ovarian cancer	0.000254	0.000348	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK1—ovarian cancer	0.000254	0.00133	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000253	0.00133	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PARP1—ovarian cancer	0.000253	0.00133	CbGpPWpGaD
Acamprosate—Pruritus—Epirubicin—ovarian cancer	0.000251	0.000343	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—IL6ST—ovarian cancer	0.00025	0.00131	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—ovarian cancer	0.00025	0.00131	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK1—ovarian cancer	0.000248	0.0013	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—ovarian cancer	0.000243	0.000332	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—IL6ST—ovarian cancer	0.000242	0.00127	CbGpPWpGaD
Acamprosate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000242	0.000331	CcSEcCtD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000239	0.00126	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—ovarian cancer	0.000239	0.00125	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000236	0.00124	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—ovarian cancer	0.000235	0.000322	CcSEcCtD
Acamprosate—Dizziness—Epirubicin—ovarian cancer	0.000234	0.000321	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—ovarian cancer	0.000233	0.00122	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—ovarian cancer	0.000232	0.000318	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000231	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—ovarian cancer	0.000229	0.0012	CbGpPWpGaD
Acamprosate—Vomiting—Epirubicin—ovarian cancer	0.000225	0.000309	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000225	0.00118	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAPK1—ovarian cancer	0.000225	0.00118	CbGpPWpGaD
Acamprosate—Diarrhoea—Doxorubicin—ovarian cancer	0.000224	0.000307	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000224	0.00118	CbGpPWpGaD
Acamprosate—Rash—Epirubicin—ovarian cancer	0.000224	0.000306	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—ovarian cancer	0.000223	0.000306	CcSEcCtD
Acamprosate—Headache—Epirubicin—ovarian cancer	0.000222	0.000304	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	0.000219	0.00115	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000219	0.00115	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—ovarian cancer	0.000219	0.00115	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—ovarian cancer	0.000217	0.000297	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MMP2—ovarian cancer	0.000213	0.00112	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000212	0.00111	CbGpPWpGaD
Acamprosate—Nausea—Epirubicin—ovarian cancer	0.000211	0.000288	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—MAPK1—ovarian cancer	0.000209	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000209	0.0011	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—ovarian cancer	0.000209	0.000285	CcSEcCtD
Acamprosate—Rash—Doxorubicin—ovarian cancer	0.000207	0.000283	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—ovarian cancer	0.000207	0.000283	CcSEcCtD
Acamprosate—Headache—Doxorubicin—ovarian cancer	0.000205	0.000281	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PPP2R1A—ovarian cancer	0.000205	0.00108	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—ovarian cancer	0.000205	0.00107	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—ovarian cancer	0.000204	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000203	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—ovarian cancer	0.000199	0.00104	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000196	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000195	0.00103	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—ovarian cancer	0.000195	0.000267	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—ERBB2—ovarian cancer	0.000192	0.00101	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00019	0.001	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—ovarian cancer	0.000189	0.000991	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—ovarian cancer	0.000187	0.000982	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—ovarian cancer	0.000187	0.000981	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000185	0.000969	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	0.000184	0.000968	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6ST—ovarian cancer	0.000183	0.000962	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000183	0.000962	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—ovarian cancer	0.000182	0.000958	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—HRAS—ovarian cancer	0.00018	0.000948	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—ovarian cancer	0.00018	0.000947	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—ovarian cancer	0.00018	0.000946	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.00018	0.000944	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000179	0.000942	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6ST—ovarian cancer	0.000179	0.000938	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—ovarian cancer	0.000178	0.000936	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000177	0.000928	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000176	0.000925	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	0.000176	0.000925	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—ovarian cancer	0.000176	0.000922	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000173	0.00091	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAPK1—ovarian cancer	0.000172	0.000901	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000171	0.0009	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—ovarian cancer	0.000171	0.0009	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.00017	0.000894	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00017	0.000894	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000168	0.000884	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—ovarian cancer	0.000168	0.000881	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	0.000168	0.00088	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—ovarian cancer	0.000164	0.000863	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—ovarian cancer	0.000164	0.00086	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—ovarian cancer	0.000163	0.000857	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—ovarian cancer	0.00016	0.000841	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000157	0.000824	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—ovarian cancer	0.000156	0.000819	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000154	0.000809	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000153	0.000803	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—ovarian cancer	0.000152	0.000799	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—ovarian cancer	0.000151	0.000793	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.00015	0.000787	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAPK1—ovarian cancer	0.00015	0.000786	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000149	0.000781	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—ovarian cancer	0.000148	0.000775	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000147	0.000773	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAPK1—ovarian cancer	0.000146	0.000766	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—NRAS—ovarian cancer	0.000146	0.000765	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—ovarian cancer	0.000145	0.000764	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—ovarian cancer	0.000144	0.000755	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6ST—ovarian cancer	0.000143	0.000751	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—NRAS—ovarian cancer	0.000142	0.000746	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—ovarian cancer	0.00014	0.000733	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—ovarian cancer	0.000138	0.000724	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000138	0.000723	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—ovarian cancer	0.000137	0.000722	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—ovarian cancer	0.000137	0.000722	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—ovarian cancer	0.000137	0.000722	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000137	0.000719	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—ovarian cancer	0.000137	0.000718	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK3—ovarian cancer	0.000136	0.000715	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000135	0.00071	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	0.000135	0.000707	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000134	0.000706	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—ovarian cancer	0.000133	0.0007	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK1—ovarian cancer	0.000133	0.000698	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—ovarian cancer	0.000133	0.000697	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—ovarian cancer	0.000132	0.000691	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK1—ovarian cancer	0.000129	0.00068	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—ovarian cancer	0.000129	0.00068	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000129	0.000677	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000127	0.000665	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—ovarian cancer	0.000125	0.000659	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK1—ovarian cancer	0.000125	0.000658	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—ovarian cancer	0.000125	0.000658	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—ovarian cancer	0.000122	0.000642	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—ovarian cancer	0.000121	0.000635	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—ovarian cancer	0.00012	0.000631	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—ovarian cancer	0.00012	0.000629	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—ovarian cancer	0.00012	0.000628	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	0.000119	0.000624	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—ovarian cancer	0.000118	0.000621	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000118	0.00062	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000117	0.000617	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—ovarian cancer	0.000117	0.000616	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—ovarian cancer	0.000117	0.000615	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—ovarian cancer	0.000117	0.000612	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—ovarian cancer	0.000114	0.0006	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000111	0.000581	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—ovarian cancer	0.000109	0.000571	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—ovarian cancer	0.000107	0.000561	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—ovarian cancer	0.000107	0.00056	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—ovarian cancer	0.000105	0.000553	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—ovarian cancer	0.000105	0.000553	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—ovarian cancer	0.000105	0.000553	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—ovarian cancer	0.000104	0.000548	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—ovarian cancer	0.000104	0.000546	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—ovarian cancer	0.000104	0.000546	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000104	0.000545	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000103	0.000543	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—ovarian cancer	0.000103	0.000539	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—ovarian cancer	0.000102	0.000536	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—ovarian cancer	0.000102	0.000534	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000102	0.000534	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRAS—ovarian cancer	0.000101	0.000532	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—ovarian cancer	0.000101	0.000532	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—ovarian cancer	0.000101	0.000528	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—ovarian cancer	9.96e-05	0.000523	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—ovarian cancer	9.95e-05	0.000522	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—ovarian cancer	9.88e-05	0.000519	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAPK1—ovarian cancer	9.87e-05	0.000519	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—ovarian cancer	9.78e-05	0.000514	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—ovarian cancer	9.71e-05	0.00051	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAPK1—ovarian cancer	9.7e-05	0.000509	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—ovarian cancer	9.69e-05	0.000509	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—ovarian cancer	9.67e-05	0.000508	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—ovarian cancer	9.62e-05	0.000505	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK1—ovarian cancer	9.48e-05	0.000498	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—ovarian cancer	9.48e-05	0.000498	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—ovarian cancer	9.43e-05	0.000495	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—ovarian cancer	9.34e-05	0.00049	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK1—ovarian cancer	9.24e-05	0.000485	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—ovarian cancer	9.24e-05	0.000485	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—ovarian cancer	9.15e-05	0.000481	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—ovarian cancer	9.1e-05	0.000478	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—ovarian cancer	8.95e-05	0.00047	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.88e-05	0.000466	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—ovarian cancer	8.88e-05	0.000466	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—ovarian cancer	8.73e-05	0.000458	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAPK1—ovarian cancer	8.48e-05	0.000445	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—ovarian cancer	8.22e-05	0.000432	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—ovarian cancer	8.14e-05	0.000427	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—ovarian cancer	8.12e-05	0.000426	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—ovarian cancer	7.93e-05	0.000416	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—ovarian cancer	7.78e-05	0.000409	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—ovarian cancer	7.78e-05	0.000408	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—ovarian cancer	7.61e-05	0.0004	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—ovarian cancer	7.56e-05	0.000397	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—ovarian cancer	7.42e-05	0.00039	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK1—ovarian cancer	7.4e-05	0.000389	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—ovarian cancer	7.4e-05	0.000389	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—ovarian cancer	7.28e-05	0.000382	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—ovarian cancer	7.1e-05	0.000373	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—ovarian cancer	6.99e-05	0.000367	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—ovarian cancer	6.8e-05	0.000357	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—ovarian cancer	6.72e-05	0.000353	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—ovarian cancer	6.55e-05	0.000344	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—ovarian cancer	6.42e-05	0.000337	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—ovarian cancer	6.21e-05	0.000326	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—ovarian cancer	5.94e-05	0.000312	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—ovarian cancer	5.69e-05	0.000299	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—ovarian cancer	5.25e-05	0.000275	CbGpPWpGaD
